Who are ClearPoint Neuro, Inc.'s major customers?

ClearPoint Neuro, Inc. (CLPT) key customers include: PHARMACEUTICAL-CUSTOMER, ONE-ADDITIONAL-CUSTOMER. View the full customer network at chainsifter.com/chain/CLPT.

What sector is ClearPoint Neuro, Inc. in?

ClearPoint Neuro, Inc. (CLPT) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

CLPT Supply Chain: ClearPoint Neuro, Inc. Suppliers & Customers

0Suppliers

2Customers

3Debt Items

12Related Chains

ClearPoint Neuro, Inc. Suppliers

No suppliers on recordClearPoint Neuro, Inc. has not yet been matched to upstream suppliers in our database, or is still being processed.

ClearPoint Neuro, Inc. Customers

Ticker	Name	Confidence	Evidence
PHARMACEUTICAL-CUSTOMER	PHARMACEUTICAL-CUSTOMER	92%	One pharmaceutical customer, a related party who is a former stockholder and former noteholder, and whose chief executive officer is a member of the Company's Board of Directors, for whom the Company…
ONE-ADDITIONAL-CUSTOMER	ONE-ADDITIONAL-CUSTOMER	90%	There was one additional customer who accounted for 11 % of the total sales for the three months ended March 31, 2025

ClearPoint Neuro, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
CLPT-DEBT	Debt stack $63.6M	90%	Market cache reports total debt of $63.6M.
CLPT-DEBT-8695	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2021-12-31.
CLPT-DEBT-8694	Warrants outstanding: 1300000	90%	xbrl warrant detail from xbrl 2019-12-31.

ClearPoint Neuro, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for ClearPoint Neuro, Inc..

ClearPoint Neuro, Inc. Ownership

Holder	Name	Confidence	Evidence
CLPT-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC	VANGUARD CAPITAL MANAGEMENT LLC	90%	13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 123 tracked holders.

ClearPoint Neuro, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
LXEO	Lexeo Therapeutics, Inc.	100.00	2
TRDA	Entrada Therapeutics, Inc.	100.00	2
RNA	Atrium Therapeutics, Inc.	100.00	2
ROCHE	ROCHE	100.00	2
KROS	Keros Therapeutics, Inc.	50.00	2
RGNX	REGENXBIO Inc.	50.00	2
AKCEA	AKCEA	50.00	2
PTCT	PTC Therapeutics, Inc.	36.29	1	['spend']
RPI	RPI	24.13	2
NVSEF	Novartis AG	14.78	2
RPRX	Royalty Pharma plc	14.78	2
IONS	Ionis Pharmaceuticals, Inc.	14.78	2

ClearPoint Neuro, Inc. Supply Chain